Boai NKY Pharmaceuticals Ltd (300109) — Financial Flexibility Index
Boai NKY Pharmaceuticals Ltd (300109) has a Financial Flexibility Index of 0.33x as of September 2025. Free cash flow of CN¥180.87 Million (operating CF CN¥139.46 Million minus capex CN¥41.41 Million) represents 0% of total liabilities (CN¥552.11 Million). Also explore Boai NKY Pharmaceuticals Ltd (300109) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Boai NKY Pharmaceuticals Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Boai NKY Pharmaceuticals Ltd across 19 annual periods. Check Boai NKY Pharmaceuticals Ltd (300109) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Boai NKY Pharmaceuticals Ltd. For the full company profile including market capitalisation, see how much is Boai NKY Pharmaceuticals Ltd worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥558.53 Million | CN¥338.11 Million | CN¥713.16 Million | ▲ +12.8% |
| 2024 | 0.69x | CN¥530.72 Million | CN¥256.03 Million | CN¥764.37 Million | ▼ -59.9% |
| 2023 | 1.73x | CN¥866.14 Million | CN¥488.25 Million | CN¥499.66 Million | ▲ +99.6% |
| 2022 | 0.87x | CN¥517.77 Million | CN¥251.77 Million | CN¥596.29 Million | ▲ +88.4% |
| 2021 | 0.46x | CN¥271.76 Million | CN¥43.44 Million | CN¥589.76 Million | ▲ +34.6% |
| 2020 | 0.34x | CN¥366.11 Million | CN¥266.87 Million | CN¥1.07 Billion | ▲ +76.5% |
| 2019 | 0.19x | CN¥221.99 Million | CN¥79.64 Million | CN¥1.14 Billion | ▲ +15.0% |
| 2018 | 0.17x | CN¥173.18 Million | CN¥48.81 Million | CN¥1.03 Billion | ▼ -37.3% |
| 2017 | 0.27x | CN¥176.51 Million | CN¥47.28 Million | CN¥656.22 Million | ▼ -86.2% |
| 2016 | 1.95x | CN¥162.61 Million | CN¥114.14 Million | CN¥83.32 Million | ▲ +36.4% |
| 2015 | 1.43x | CN¥104.59 Million | CN¥64.12 Million | CN¥73.11 Million | ▲ +13.6% |
| 2014 | 1.26x | CN¥93.71 Million | CN¥46.60 Million | CN¥74.38 Million | ▼ -2.1% |
| 2013 | 1.29x | CN¥58.65 Million | CN¥23.17 Million | CN¥45.58 Million | ▼ -47.2% |
| 2012 | 2.44x | CN¥111.61 Million | CN¥20.65 Million | CN¥45.81 Million | ▼ -12.7% |
| 2011 | 2.79x | CN¥108.24 Million | CN¥3.94 Million | CN¥38.80 Million | ▲ +118.3% |
| 2010 | 1.28x | CN¥31.43 Million | CN¥10.05 Million | CN¥24.60 Million | ▲ +15.5% |
| 2009 | 1.11x | CN¥53.84 Million | CN¥28.57 Million | CN¥48.66 Million | ▲ +864.4% |
| 2008 | 0.11x | CN¥5.45 Million | CN¥-4.09 Million | CN¥47.52 Million | ▼ -60.9% |
| 2007 | 0.29x | CN¥14.33 Million | CN¥9.56 Million | CN¥48.84 Million | — |